Compare · CI vs CLOV
CI vs CLOV
Side-by-side comparison of The Cigna Group (CI) and Clover Health Investments Corp. (CLOV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CI and CLOV operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $74.11B, about 33.9x CLOV ($2.18B).
- Over the past year, CI is down 6.7% and CLOV is up 55.3% - CLOV leads by 62.0 points.
- CLOV has been more active in the news (8 items in the past 4 weeks vs 7 for CI).
- CI has more recent analyst coverage (25 ratings vs 12 for CLOV).
- Company
- The Cigna Group
- Clover Health Investments Corp.
- Price
- $280.36+0.98%
- $4.10-1.44%
- Market cap
- $74.11B
- $2.18B
- 1M return
- -3.19%
- -5.09%
- 1Y return
- -6.73%
- +55.30%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 8
- Recent ratings
- 25
- 12
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Clover Health Investments Corp.
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.
Latest CI
- SEC Form 4 filed by Officer Holgerson Bryan
- Officer Jones Nicole S sold $748,516 worth of shares (2,677 units at $279.61) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 25,880 units (SEC Form 4)
- SEC Form 144 filed by The Cigna Group
- Officer Jones Nicole S exercised 15,346 shares at a strike of $192.02 and sold $5,369,584 worth of shares (19,436 units at $276.27) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 28,557 units (SEC Form 4)
- SEC Form 144 filed by The Cigna Group
- The Cigna Group downgraded by Jefferies with a new price target
- The Cigna Group downgraded by Raymond James with a new price target
- SEC Form 10-Q filed by The Cigna Group
- The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook
Latest CLOV
- Clover Health Investments Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Interim CFO Thornton Joseph Clay sold $78,032 worth of shares (17,775 units at $4.39), decreasing direct ownership by 1% to 1,249,526 units (SEC Form 4) (tax liability)
- Chief Legal Officer Soares Karen was granted 108,695 shares, increasing direct ownership by 7% to 1,614,217 units (SEC Form 4)
- Interim CFO Thornton Joseph Clay was granted 54,347 shares, increasing direct ownership by 4% to 1,267,301 units (SEC Form 4)
- Chief Executive Officer Toy Andrew sold $408,261 worth of shares (87,798 units at $4.65), decreasing direct ownership by 0.92% to 9,459,316 units (SEC Form 4) to satisfy withholding tax
- SEC Form 10-Q filed by Clover Health Investments Corp.
- Clover Health Investments Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Clover Health Reports Second Quarter 2026 Results
- Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
- Chief Legal Officer Soares Karen sold $233,167 worth of shares (51,700 units at $4.51) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,505,522 units (SEC Form 4)